{"organizations": [], "uuid": "e65eae49a55661060d75c4abaee3f62e9868ead5", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180221.html", "section_title": "Archive News &amp; Video for Wednesday, 21 Feb 2018 | Reuters.com", "url": "https://www.reuters.com/article/brief-easywell-biomedicals-us-unit-tulex/brief-easywell-biomedicals-u-s-unit-tulex-pharmaceuticals-signs-agreement-with-well-known-transnational-pharmaceutical-company-idUSL4N1QC0KP", "country": "US", "domain_rank": 408, "title": "BRIEF-Easywell Biomedicals U.S. unit Tulex Pharmaceuticals signs agreement with well-known transnational pharmaceutical company", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.442, "site_type": "news", "published": "2018-02-22T09:51:00.000+02:00", "replies_count": 0, "uuid": "e65eae49a55661060d75c4abaee3f62e9868ead5"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-easywell-biomedicals-us-unit-tulex/brief-easywell-biomedicals-u-s-unit-tulex-pharmaceuticals-signs-agreement-with-well-known-transnational-pharmaceutical-company-idUSL4N1QC0KP", "ord_in_thread": 0, "title": "BRIEF-Easywell Biomedicals U.S. unit Tulex Pharmaceuticals signs agreement with well-known transnational pharmaceutical company", "locations": [], "entities": {"persons": [], "locations": [{"name": "u.s.", "sentiment": "none"}], "organizations": [{"name": "reuters", "sentiment": "negative"}, {"name": "tulex pharmaceuticals", "sentiment": "negative"}, {"name": "brief-easywell biomedicals u.s.", "sentiment": "negative"}, {"name": "easywell biomedicals inc", "sentiment": "negative"}, {"name": "beijing headline news", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "Feb 22 (Reuters) - Easywell Biomedicals Inc :\n* Says its U.S. unit Tulex Pharmaceuticals signs agreement with a well-known transnational pharmaceutical company on new drug development\nSource text in Chinese: goo.gl/L7xTxU\nFurther company coverage: (Beijing Headline News)\n ", "external_links": ["https://goo.gl/L7xTxU", "http://thomsonreuters.com/en/about-us/trust-principles.html"], "published": "2018-02-22T09:51:00.000+02:00", "crawled": "2018-02-22T17:53:39.006+02:00", "highlightTitle": ""}